The formula for the DAS28 score explains much of the problem: ESR scores are log-transformed, so changes at the top end of the scale have little influence on DAS28, whereas a small change in ESR ...

Please provide your email address to receive an email when new articles are posted on . DAS28 remission was commonly linked with clinical disease activity despite more stringent cut-points, according ...

Zimlovisertib plus tofacitinib showed greater efficacy than tofacitinib alone in reducing Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) in patients with rheumatoid arthritis ...

Please provide your email address to receive an email when new articles are posted on . Machine learning methods combining pharmacogenomic biomarkers with baseline Disease Activity Score-28 joint ...

Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for rheumatoid arthritis. In this phase 3, double ...

Older age and low literacy were not barriers to self-monitoring and reporting disease activity. A common treatment approach in RA, a chronic inflammatory disease, treat to target, which sets specific ...

Peresolimab is a humanized IgG1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway. Stimulation of this pathway would be a novel ...